Dr. Siddiqi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2011 Zonal Ave
# Hmr
Los Angeles, CA 90089Phone+1 323-442-2582Fax+1 323-442-2588
Summary
- Dr. Imran Siddiqi is a pathologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Keck Hospital of USC, Los Angeles Community Hospital at Los Angeles, and USC Norris Comprehensive Cancer Center. He received his medical degree from University of California Irvine School of Medicine and has been in practice 15 years. He specializes in hematopathology, anatomic pathology, and clinical pathology.
Education & Training
- University of California (San Francisco)Fellowship, Hematopathology, 2006 - 2007
- University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 2002 - 2006
- University of California, Irvine, School of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2004 - 2025
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- T-Cell Prolymphocytic Leukemia With PDGFRB Rearrangement in the Setting of Neurofibromatosis Type 1.Yue Zhao, Philip Petersen, Imran Siddiqi, Endi Wang
International Journal of Laboratory Hematology. 2025-01-16 - Concomitant Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma and Non-Immunoglobulin M Plasma Cell Neoplasm.Yue Zhao, Philip Petersen, Sophie Stuart, Jiaqi He, Yaping Ju
Archives of Pathology & Laboratory Medicine. 2025-01-13 - CD10-Positive Lymphoplasmacytic Lymphoma: A Diagnostic Pitfall.Yaping Ju, Sophie Stuart, Yue Zhao, Yi Xie, Luis F Carrillo
Clinical Lymphoma, Myeloma & Leukemia. 2025-01-01
Press Mentions
- Deadliest Cancers May Respond to New Drug Treatment StrategyJanuary 29th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: